Position in DXCM
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$18,117
+$1,350 QoQ
Shares Held
269
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#808
of 973 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026American Capital Advisory, LLC holds $137,942 across 16 Medical Devices names. DXCM ranks #3 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
838 | $76,040 | |
| 2 | EW |
Edwards Lifesciences Corp
|
275 | $24,876 | |
| 3 | DXCM |
Dexcom Inc
This page
|
269 | $18,117 | |
| 4 | SYK |
Stryker Corp
|
15 | $4,722 | |
| 5 | MDT |
Medtronic plc
|
52 | $4,067 | |
| 6 | PODD |
Insulet Corp
|
11 | $1,674 | |
| 7 | COCH |
Envoy Medical, Inc.
|
2,000 | $1,584 | |
| 8 | BSX |
Boston Scientific Corp
|
36 | $1,536 |
All Filings in DXCM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,117 | 269 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $16,767 | 267 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $17,455 | 263 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $17,428 | 259 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $22,695 | 260 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $17,072 | 250 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $19,442 | 250 | Shares | Sole | 2025-01-28 | |
| 2024-06-30 | $21,542 | 190 | Shares | Sole | 2024-07-29 | |
| 2023-12-31 | $23,577 | 190 | Shares | Sole | 2024-04-09 | |
| No filing history on record for this holder in this stock. | ||||||